Potential of regulatory T cell-based therapies in the management of severe COVID-19 - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles European Respiratory Journal Year : 2020

Potential of regulatory T cell-based therapies in the management of severe COVID-19

Abstract

In view of dysregulated immune response, cytokine storm and inflammation-induced severe lung damage in severely ill COVID-19 patients, we propose that CD4+CD25+FoxP3+ regulatory T cell-based therapies could be considered for the patient management
Embargoed file
Embargoed file
Visibility date is undetermined
Loading...

Dates and versions

inserm-02879881 , version 1 (24-06-2020)

Licence

Attribution - NonCommercial

Identifiers

Cite

Emmanuel Stephen-Victor, Mrinmoy Das, Anupama Karnam, Bruno Pitard, Jean-François Gautier, et al.. Potential of regulatory T cell-based therapies in the management of severe COVID-19. European Respiratory Journal, 2020, ⟨10.1183/13993003.02182-2020⟩. ⟨inserm-02879881⟩
141 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More